MALLORY BALLARD: Open Payments
NPI 1972177251 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,475 in 139 payments from 15 companies in 2025. Trend: 2023 $2,610 · 2024 $2,260 · 2025 $2,475
Food & beverage: $2,196Education: $279
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $367 |
| Lilly USA, LLC | 20 | $332 |
| Janssen Biotech, Inc. | 18 | $321 |
| LEO Pharma Inc. | 14 | $285 |
| Novartis Pharmaceuticals Corporation | 12 | $274 |
| UCB, Inc. | 19 | $269 |
| E.R. Squibb & Sons, L.L.C. | 21 | $160 |
| GENZYME CORPORATION | 5 | $134 |
| Eli Lilly and Company | 1 | $99 |
| ABBVIE INC. | 5 | $97 |
Products named: TREMFYA, ILUMYA, Bimzelx, TALTZ, COSENTYX, Sotyktu, DUPIXENT, ANZUPGO.
Industry payments across AR — which companies pay providers there.
